Clinical Trial Update: Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ABX464 as maintenance therapy for moderate-to-severe ulcerative colitis has completed and posted results, including efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ABX464 (ABX464)

Snippet

Sponsor: Abivax S.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2025-04-27